Warfarin Therapy Management
Initial Warfarin Dosing
- The American College of Cardiology recommends starting with 5 mg daily for most patients, which typically results in an INR of 2.0 after 4-5 days, with lower starting doses (2-4 mg) used in elderly patients, those at increased bleeding risk, or patients likely to be sensitive to warfarin 1
- When rapid anticoagulation is required, the American College of Cardiology suggests administering heparin concurrently with warfarin for at least 4 days, continuing heparin until the INR has been in therapeutic range for 2 consecutive days 1
INR Monitoring Schedule
- The American College of Cardiology recommends checking INR daily until therapeutic range is reached and sustained for 2 consecutive days, then checking 2-3 times weekly for 1-2 weeks, and then less frequently according to stability of results 1
- Once stable, INR monitoring can be reduced to intervals as long as 4 weeks, according to the American College of Cardiology 1, 2
Target INR Ranges
- The American College of Cardiology recommends an INR range of 2.0-3.0 for most indications, including venous thromboembolism and atrial fibrillation 3, 1
Dose Adjustment Guidelines
- For INR within therapeutic range, the American College of Cardiology recommends continuing the current dose 4, 5
- For INR above therapeutic range but <5 (without bleeding), the American College of Cardiology suggests reducing the daily dose until INR returns to therapeutic range 4, 5
Perioperative Management
- For low-risk procedures, the American College of Cardiology recommends continuing warfarin therapy and checking INR during the week before the procedure to ensure it's within therapeutic range 4, 6
- For high-risk procedures with low thrombotic risk, the American College of Cardiology suggests stopping warfarin 5 days before the procedure, checking INR prior to the procedure to ensure it's <1.5, and restarting warfarin with the usual daily dose on the evening of the procedure 4, 6
- For high-risk procedures with high thrombotic risk, the American College of Cardiology recommends stopping warfarin 5 days before the procedure, starting therapeutic dose LMWH two days after stopping warfarin, and administering the last dose of LMWH at least 24 hours before the procedure 4, 6
Special Considerations
- The American College of Cardiology advises all patients on warfarin that they have an increased risk of post-procedure bleeding compared to non-anticoagulated patients 4, 5
- Factors increasing bleeding risk include advanced age, history of bleeding, and comorbidities such as renal insufficiency or anemia, according to the American College of Cardiology 7
- The American College of Cardiology suggests that point-of-care testing may be appropriate for some patients, allowing home monitoring 1, 2
- For patients who have experienced bleeding during therapeutic warfarin therapy but require continued anticoagulation, the American College of Cardiology recommends considering lower target INR ranges (e.g., 2.0-2.5 for mechanical heart valves, 1.5-2.0 for atrial fibrillation) 7
Warfarin Management for Low Bleeding Risk Procedures
General Recommendations
- The American College of Chest Physicians guidelines note that minor procedures with anticipated minimal bleeding may require only a shorter interruption interval or none at all, such as breast biopsy, which is considered a low bleeding risk procedure 8, 9
- For patients undergoing breast core needle biopsy, the general perioperative guidelines that recommend 5-day warfarin interruption for high-risk procedures do not apply, and warfarin can be continued without interruption 8, 9
Practical Management Approach
- If warfarin must be held, it should be stopped 5 days before the procedure, and INR should be checked prior to the procedure to ensure it is less than 1.5, with warfarin resumed at the usual dose on the evening of the procedure 8